Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jan;196(1):95-97.
doi: 10.1007/s00066-019-01545-3.

[Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC-a breakthrough]

[Article in German]
Matthias Guckenberger  1
Affiliations
Comment

[Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC-a breakthrough]

[Article in German]
Matthias Guckenberger. Strahlenther Onkol. 2020 Jan.
No abstract available

PubMed Disclaimer

Comment on

  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
    Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280658 Clinical Trial.

Similar articles

See all similar articles

Cited by

References

    1. N Engl J Med. 2018 Jun 14;378(24):2288-2301 - PubMed
    1. Lancet. 2015 Sep 12;386(9998):1049-56 - PubMed
    1. J Clin Oncol. 2015 Dec 10;33(35):4194-201 - PubMed
    1. Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21 - PubMed
    1. N Engl J Med. 2016 Nov 10;375(19):1823-1833 - PubMed

LinkOut - more resources